the current bsh guidelines for the diagnosis and evaluation of prognosis of myelofibrosis
Published 3 months ago • 78 plays • Length 1:13Download video MP4
Download video MP3
Similar videos
-
1:34
updated bsh guidelines for managing dlbcl
-
2:25
key ebmt guideline updates for the treatment and prophylaxis of gvhd
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
8:57
outcomes of sct in t-all and t-lbl
-
1:41:21
recent advances in thalassemia
-
26:46
webinar recording | technology advances in hematology testing | sparrc 2021 by srmc | mindray india
-
0:45
current landscape of treatment for scd: an update from ash 2023
-
1:59
session overview: pitfalls in the diagnosis of bleeding disorders & research networks in the uk
-
0:48
asciminib for the treatment of cml
-
1:03
late effect surveillance following allosct: the publication of new guidelines
-
1:21
trends in allosct for good-risk aml: a longitudinal study
-
1:23
the current landscape of treatment for hr-mds: an update from ash 2023
-
2:11
update on phase i/ii study of azacitidine, venetoclax and gilteritinib in patients with flt3 aml
-
2:41
an overview of the latest advances in hematology
-
2:55
current and emerging treatments for mf: an update from ash 2023
-
2:43
the management of advanced phase mpns
-
3:02
novel treatments and ongoing clinical trials for wm: targeted agents and immunotherapies
-
1:47
the need for new diagnostic criteria in vod
-
2:25
a final update of enhance: reflecting on the negative read-out of the study
-
1:36
translational aspects of mpns: investigating disease biology